Recombinantly expressed VP1-virus-like particles (VP1-VLP) of human polyomavirus JC virus (JCV) were described recently as a new DNA transporter system. It was shown that DNA molecules could be packaged into VP1-VLP during a controlled chemical reassociation/dissociation process. In the present study VP1-VLP were studied as carriers for pharmaceutical substances. Propidium iodide (PI) was packaged into VP1-VLP as a reporter molecule. The PI-containing VP1-VLP could be detected directly by flow cytometry. The fluorescence intensity of the VP1-VLP depended strongly on the initial PI concentration. This packaging method is easy to handle and applicable to viruses and VP1-VLP which can be dissociated and reassociated chemically.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0166-0934(00)00226-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Novel polyomavirus in the endangered garden dormouse Eliomys quercinus.
Virol J
November 2024
Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio al. 7, Vilnius, LT-10257, Lithuania.
Article Synopsis
- The garden dormouse's population in Europe has declined significantly due to factors like habitat loss, climate change, and potentially pathogen exposure.
- In a study involving 89 garden dormice from Germany, researchers tested kidney samples for polyomavirus DNA and checked for antibodies in their body fluids.
- A new polyomavirus related to other known polyomaviruses was identified, with a small percentage of dormice testing positive for the virus, suggesting that further research is needed to determine its significance and specificity to the garden dormouse.
Viral Protein VP1 Virus-like Particles (VLP) of CVB4 Induces Protective Immunity against Lethal Challenges with Diabetogenic E2 and Wild Type JBV Strains in Mice Model.
Viruses
March 2023
Research Unit UR17ES30 «Virology & Antiviral Strategies», Institute of Biotechnology, University of Monastir, Monastir 5000, Tunisia.
Several epidemiological studies demonstrated that coxsackievirus B4 (CVB4) causes viral pancreatitis and can ultimately result in type 1 diabetes mellitus (T1D). Prevention of CVB4 infection is therefore highly desirable. There is currently no vaccine or antiviral therapeutic reagent in clinical use.
View Article and Find Full Text PDFEffect of dsDNA on the Assembly Pathway and Mechanical Strength of SV40 VP1 Virus-like Particles.
Biophys J
November 2018
Moleculaire Biofysica, Zernike Instituut, Rijksuniversiteit Groningen, Groningen, The Netherlands. Electronic address:
Simian virus 40 (SV40) is a possible vehicle for targeted drug delivery systems because of its low immunogenicity, high infectivity, and high transfection efficiency. To use SV40 for biotechnology applications, more information is needed on its assembly process to efficiently incorporate foreign materials and to tune the mechanical properties of the structure. We use atomic force microscopy to determine the effect of double-stranded DNA packaging, buffer conditions, and incubation time on the morphology and strength of virus-like particles (VLPs) composed of SV40 VP1 pentamers.
View Article and Find Full Text PDFDevelopment and Evaluation of a Broad Bead-Based Multiplex Immunoassay To Measure IgG Seroreactivity against Human Polyomaviruses.
J Clin Microbiol
April 2018
Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands
The family of polyomaviruses, which cause severe disease in immunocompromised hosts, has expanded substantially in recent years. To accommodate measurement of IgG seroresponses against all currently known human polyomaviruses (HPyVs), including the Lyon IARC polyomavirus (LIPyV), we extended our custom multiplex bead-based HPyV immunoassay and evaluated the performance of this pan-HPyV immunoassay. The VP1 proteins of 15 HPyVs belonging to 13 species were expressed as recombinant glutathione -transferase (GST) fusion proteins and coupled to fluorescent Luminex beads.
View Article and Find Full Text PDFOptimizing JC and BK polyomavirus IgG testing for seroepidemiology and patient counseling.
J Clin Virol
October 2015
Transplantation & Clinical Virology, Department Biomedicine - Haus Petersplatz, University of Basel, Basel, Switzerland; Infection Diagnostics, Department Biomedicine - Haus Petersplatz, University of Basel, Basel, Switzerland; Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland. Electronic address:
Background: Polyomavirus JC (JCPyV) and BK (BKPyV) can cause significant diseases in immunocompromised patients including nephropathy, hemorrhagic cystitis, and leukoencephalopathy. Recently, JCPyV and BKPyV IgG have been explored as risk predictors in multiple sclerosis and transplant patients, but sensitivity, specificity and quantification issues limit current performance.
Objective: To improve JCPyV and BKPyV-specific antibody testing.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!